Rosacea: a symptom-based approach to management Edward Seaton MA, MRCP
|
|
- Darren Ross
- 5 years ago
- Views:
Transcription
1 Rosacea: a symptom-based approach to management Edward Seaton MA, MRCP VM Rosacea is a common skin condition of unknown aetiology. Dr Seaton describes the recommended management of the vascular and inflammatory symptoms. Figure 1. with features of persistent erythema and inflammatory papules and pustules; azelaic acid gel is the first-line topical treatment Rosacea is a chronic skin disease usually affecting the convex surfaces of the face in which a pattern of symptoms occurs, including facial flushing, erythema, telangiectasia, inflammatory papules or pustules and swelling (phymomas). It used to be thought that patients progressed from a propensity to flushing, through persistent erythema, to inflammation and eventually to phymomatous change, but it is now recognised that very different subtypes of rosacea exist, perhaps representing separate conditions altogether, and that most patients do not follow this strict progression. Incidence Rosacea is common, although the exact prevalence is unknown. It is commoner in fair-skinned (Celtic and northern European) races and very rare in black people. It accounts for 1-3 per cent of dermatology consultations in Sweden. Women are more commonly affected than men, although rhinophyma is uncommon in females. Rosacea usually starts between the ages of 30 and 50. Aetiology The cause of rosacea is unknown, but several factors have been proposed. Abnormal vascular reactivity Prominent flushing is a common feature in rosacea. Patients have an elevated resting facial blood flow that also increases abnormally in reaction to warming. It has been suggested that rosacea Prescriber 5 April
2 prolonged flushing dietary, environmental and emotional triggers persistent erythema sparing concavities burning, stinging and pain telangiectasias no inflammatory lesions persistent erythema sparing concavities flushing inflammatory papules and pustules tissue swelling as late event persistent swelling of nose, chin, forehead, cheeks or ears prominent pores thickened skin nodular, moonscape-like appearance as late event commoner in men itch, burning, stinging, dryness or watering blepharoconjunctivitis, chalazion or hordeolum may occur keratitis or visual disturbance if severe Table 1. Subtypes of rosacea patients have a primary error in control of vascular tone and that secondary leakiness of vasculature promotes inflammatory papules and swelling. However, reproducible abnormalities of vascular neurotransmission have not been identified. Alteration of the dermis by climactic insults Rosacea is commoner in the fair skinned, is rare on body sites that are normally clothed, and facial erythema is seen in those exposed to chronic heat. These observations suggest that environmental, climactic insults may be important. Exposure to ultraviolet light damages dermal elastin and collagen, and in rats causes blood vessel tortuosity. It has been suggested that sluggish blood flow in tortuous vessels might cause pooling of inflammatory mediators and vasoactive agents. Microbial organisms Demodex folliculorum is a mite that inhabits the skin of almost all humans. It has been proposed as a causative organism in rosacea because: abnormally high numbers of Demodex are found in patients with papulopustular rosacea an apparently associated inflammatory response can be seen in some biopsy specimens rosacea occurs in middle age and Demodex colonisation increases with age. However, topical rosacea treatments do not alter Demodex numbers and erythematotelangiectatic rosacea (ETR) patients have normal levels of colonisation. Historical textbooks suggested a link between rosacea and dyspepsia. However gastritis or Helicobacter pylori colonisation is not consistently associated with rosacea. Improvements noted with H. pylori eradication therapy are likely related to the antibiotics themselves rather than the organism s elimination. Chemicals and ingested agents Despite popular belief, there is no demonstrable causative link between alcohol and rosacea or rhinophyma, although it may precipitate flushing attacks in rosacea patients. Clinical features A working party of the American National Rosacea Society has suggested four subclassifications (see Table 1). The ETR subtype is characterised by symptoms of vascular rosacea, that is to say prolonged flushing (lasting many minutes), persistent erythema and telangiectasia. Scaling and roughness may also occur. Such patients typically describe stinging, discomfort or pain during flushing attacks or after applying topical products. Flushing attacks are commonly induced by alcohol, hot drinks, spicy food, exercise, cold or hot weather and hot baths or showers. Caffeine itself does not induce flushing. Erythema affects the convexities of the face and spares the perioral and periocular concavities, giving an appearance of ski-goggle sunburn. The papulopustular rosacea (PPR) subtype is the classical description of rosacea. It presents with a combination of vascular and inflammatory signs. Patients have persistent erythema, with striking periocular sparing, but also inflammatory papules and pustules, which may appear in crops. Comedones (blackheads and whiteheads) are not a feature. Skin oedema may occur in longstanding disease. Chronic oedema and tissue hyperplasia can occur de novo, or as an uncommon complication of other forms of rosacea. Men are much more commonly affected. Rhinophyma is the commonest type, but the forehead, chin, cheeks, eyelids and ears can also be affected. Clinically thickened, swollen and sometimes craggy moonscape-like nodular skin with prominent pores is seen. 16 Prescriber 5 April
3 Ocular involvement in rosacea is often overlooked but probably occurs in 50 per cent of patients. Direct questioning of patients may reveal symptoms of ocular itch, irritation, burning, dryness or watering and occasionally pain or visual disturbance. On examination blepharoconjunctivitis, chalazia, hordeola (styes) and rarely keratitis may be seen. VM Differential diagnosis While classical PPR provides little diagnostic difficulty, the red face often presents a diagnostic problem even for experienced dermatologists. Seborrhoeic dermatitis, acne, contact allergic dermatitis, lupus erythematosus, Jessner s lymphocytic infiltrate, cutaneous lymphoma carcinoid syndrome, lupus pernio (sarcoidosis), squamous or basal cell carcinoma and angiosarcoma may mimic rosacea or rhinophyma. Patients should be referred to a dermatologist if there is diagnostic doubt. Treatment (see Table 2) When determining which treatment to select for rosacea, it is best to consider separately both vascular and inflammatory symptoms and signs as well as the presence of ocular involvement and swelling. By doing this, it is possible to select the most appropriate treatment for your patient. In general pharmacological treatments are useful for inflammatory disease but disappointing for vascular rosacea, which responds better to physical treatments such as intense pulsed light and lasers. Very few randomised controlled trials (RCTs) of rosacea therapies have been conducted. General measures Patients may find it useful to keep a diary to identify trigger factors Figure 2. Electrosurgery is an effective treatment for rhinophyma for flushing episodes, such as hot drinks or certain foods. Uncomfortable flushing can often be relieved by a simple moisturiser, eg aqueous cream, kept in the fridge and applied to sooth symptoms when they occur. Moisturisers are often helpful to control discomfort in rosacea and should be used in place of soaps for washing, but patients may need to try several before finding one that does not sting. Camouflage creams are very useful and can be expertly blended to suit patients skin type by the British Red Cross Camouflage Service, which runs clinics in many dermatology departments. Some clinicians suggest that sunscreen be regularly applied to prevent sunlight-induced exacerbations, but rosacea patients often have trouble finding a sunscreen that is comfortable and cosmetically acceptable. It is worth reassuring patients that progression to rhinophyma is unusual. The most effective therapies for persistent erythema are light Prescriber 5 April
4 drugs usually ineffective diary to identify triggers moisturiser as soap substitute fridge-cooled moisturiser for painful flushing cosmetic camouflage very helpful intense pulsed light highly effective topical azelaic acid first line (once daily, build up to twice daily) topical metronidazole alternative oral antibiotics for more severe disease or for rapid response second-generation tetracyclines, eg lymecycline, first line erythromycin alternative continue oral antibiotics for 2-3 months at least combine with topical azelaic acid azelaic acid for maintenance repeat courses of oral antibiotics often needed most patients do not request treatment electrosurgery and/or laser resurfacing effective oral isotretinoin useful for swelling in papulopustular rosacea artificial tears topical metronidazole gel oral second-generation tetracyclines consider referral to ophthalmologist Table 2. Recommended management of rosacea based. Intense pulsed light therapy involves irradiation of the skin with high-intensity broadspectrum light, causing thermal damage to superficial vasculature, and probably also inducing remodelling of dermal collagen. Approximately 90 per cent of patients will experience improvement after three or four treatments, although short-lived worsening of erythema and bruising can occur. Pulsed-dye lasers can also be used to treat persistent erythema and telangiectasias. Unfortunately drugs are not often useful for vascular rosacea. Topical therapies are ineffective for the prevention of flushing. Oral propranolol, clonidine or mirtazapine have been prescribed to control flushing, but their use is unlicensed and evidence largely anecdotal. Until recently, topical and systemic antibiotics were the mainstay of treatment for PPR. The efficacy of these agents is explained by their anti-inflammatory rather than any antibacterial effects. Recently a 15 per cent azelaic acid hydrogel formulation (Finacea) has become available as a novel nonantibiotic topical treatment. Metronidazole is available in several formulations ( per cent) for the topical treatment of rosacea. Metronidazole has demonstrated benefits over placebo in several RCTs and compares well with twice-daily oral tetracycline 250mg. Topical erythromycin and clindamycin can also be effective (although unlicensed). Azelaic acid is a naturally occurring dicarboxylic acid that inhibits production of reactive oxygen species by neutrophils. A recent RCT comparing 15 per cent azelaic acid gel twice daily with 0.75 per cent metronidazole gel demonstrated at least therapeutic equivalence, and probable superiority, of azelaic acid after eight weeks. Approximately one-quarter of azelaic acid patients experience short-lived stinging and 4 per cent discontinued the trial because of this. Patients can be advised to apply azelaic acid once daily for the first few weeks to improve tolerability. The increasing global prevalence of multiantibiotic-resistant micro-organisms means that antibiotic prescribing should be judicious, particularly for noninfectious diseases. For this reason, 15 per cent azelaic acid should probably be the first-line topical treatment for rosacea. Systemic antibiotics are generally reserved for patients who fail to respond to topical therapies or for those who require a rapid response. Oxytetracycline and tetracycline (250mg twice daily) can be effective, but most dermatologists use a second-generation tetracycline as first-line systemic treatment, eg lymecycline 408mg once or twice daily or doxycycline 100mg once daily. These agents have better bioavailability, can be taken with food and have longer half-lives than first-generation tetracyclines. Minocycline can cause irreversible pigmentation of the skin and is probably best avoided. Doxycycline can cause cutaneous photosensitivity. 20 Prescriber 5 April
5 The macrolides, erythromycin (500mg twice daily), clarithromycin (250mg once or twice daily) and azithromycin (250mg once or twice daily) are also effective, as is metronidazole (200mg twice daily). Antibiotic courses should be continued for at least two to three months and should be combined with topical azelaic acid if possible, which can be continued afterwards to provide maintenance. Concomitant use of different oral and topical antibiotics is best avoided. Repeated courses of oral antibiotics are often required. Oral isotretinoin has also been used in PPR, but its superiority over conventional therapy has not been demonstrated. Many patients with advanced rhinophyma will not request treatment. If required electrosurgery is an effective approach, in which the excess tissue is removed with a cutting and coagulating electrode and the nose then allowed to heal by granulation. Resurfacing laser therapy can also be used. Patients with extensive PPR and early phymatous change may improve with oral isotretinoin. Mild ocular rosacea may respond to simple measures including artificial tears and application of topical metronidazole gel to the eyelids, but systemic tetracycline is Acne Support Group (also helps rosacea patients). PO Box 9, Newquay, Cornwall, TR9 6WG. Tel: ; website (mostly acne focused): acne. British Association of Dermatologists. Patient information leaflet available online: org.uk/public/leaflets/rosacea.asp. American National Rosacea Society. Patient information available at Table 3. Sources of patient information the most effective treatment. If troublesome, referral to an ophthalmologist is advisable. Special situations: rosacea in pregnancy Severe flares of rosacea can sometimes occur in pregnancy. Topical metronidazole and oral erythromycin are not known to be harmful to the fetus, but tetracyclines are contraindicated. Manufacturers advise avoidance of azelaic acid because of insufficient data. Conclusion Treatment of rosacea can be rewarding, but it should be directed at the subtype of disease. Patients with inflammatory papules and pustules often respond well to topical 15 per cent azelaic acid or per cent metronidazole, while oral tetracyclines are useful for those who fail to respond and patients with ocular symptoms. Persistent erythema and telangiectasia respond to light and laser therapy, while electrosurgical shave excision can be performed for severe rhinophyma. However, the differential diagnosis of the red face is broad and referral to a dermatologist should be considered if there is diagnostic doubt or therapeutic failure. Further reading A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Results of a randomized trial. Elewski BE, Fleischer AB, Pariser DM. Arch Dermatol 2003;139: Rosacea. Powell FC. New Eng J Med 2005;352: Rosacea: I. Etiology, pathogenesis and subtype classification. Crawford GH, Pelle MT, James WD. J Am Acad Dermatol 2004;51: Rosacea II. Therapy. Pelle MT, Crawford GH, James WD. J Am Acad Dermatol 2004;51: Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. Wilkin J, Dahl M, Detmar M, et al. 2002;46: Systematic review of rosacea treatments. Van Zuuren EJ, Gupta AK, Gover MD, et al. J Am Acad Dermatol 2007;56: Dr Seaton is a consultant dermatologist at the Royal Free Hospital, London 22 Prescriber 5 April
Rosacea. This non promotional presentation has been sponsored and developed by Galderma for UK healthcare professionals only.
Rosacea [Speaker Name] [Title] This non promotional presentation has been sponsored and developed by OTH18-07-0214 DOP: September 2018 Learning Objectives To review current guidelines for best practice
More informationRosacea Rosacea: how I hates ya! Richard Castillo, OD, DO The Oklahoma College of Optometry Northeastern State University Tahlequah, OK
Rosacea Rosacea: how I hates ya! Richard Castillo, OD, DO The Oklahoma College of Optometry Northeastern State University Tahlequah, OK Introduction Clinical Features Flushing Telangiectasia Erythema Papules
More informationTime to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service
Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...
More informationEvidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada. Catherine Zip Nov 10, 2016
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada Catherine Zip Nov 10, 2016 Acne Acne Classification Type Comedonal Mild-to-moderate papulopustular acne Severe Description
More informationCorporate Medical Policy
Corporate Medical Policy Non-Pharmacologic Treatment of Rosacea File Name: Origination: Last CAP Review: Next CAP Review: Last Review: non-pharmacologic_treatment_of_rosacea 8/2005 11/2017 11/2018 11/2017
More informationUpdate of Rosacea. Case 1. Case 2 8/15/2017
Update of Rosacea Dr Samantha Eisman Dermatologist Sinclair Dermatology MBChB MRCP(UK) FCDerm(SA) FACD Case 1 Your 55 year old cousin calls and asks advise about her red face. What is your differential
More information资料来自互联网, 仅供科研和教学使用, 使用者请于 24 小时内自行删除
Clinical dermatology Original article CED Clinical and Experimental Dermatology A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea:
More informationACNE. What are the aims of this leaflet?
ACNE What are the aims of this leaflet? This leaflet has been written to help you understand more about acne - what it is, what causes it, what can be done about it and where you can find out more about
More informationACNE. Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211
ACNE Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211 Pathogenesis of Acne Causative Factors Therapy On the horizon Approximately 45 million Americans have acne It is often
More informationOriginal Policy Date
MP 2.01.45 Non-Pharmacologic Treatment of Rosacea Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical
More informationTwo Cases of Corneal Ulcer Caused by Ocular Rosacea: Late Versus Prompt Diagnosis and Treatment
JOURNAL OF CASE REPORTS 2016;6(2):263-267 Two Cases of Corneal Ulcer Caused by Ocular Rosacea: Late Versus Prompt Diagnosis and Treatment Anandita Widya, Susiyanti Made Infection and Immunology Division,
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) September 2014 Review date: September 2017 Bulletin 204 : Brimonidine tartrate gel (Mirvaso ) for the treatment of facial erythema of rosacea in
More informationDermatologists who keep an open mind and tailor the regimen to each individual can help steer patients toward long-term control of rosacea symptoms.
Dermatologists who keep an open mind and tailor the regimen to each individual can help steer patients toward long-term control of rosacea symptoms. By Paul Winnington, Editor-in-Chief 48 Practical Dermatology
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 January 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 January 2012 EPIDUO, gel Tube of 30 g (CIP code: 383 814-6) Tube of 60 g (CIP code: 383 816-9) Applicant: GALDERMA
More informationRosacea is a common, but often
Rosacea: A Common, Yet Commonly Overlooked, Condition B. WAYNE BLOUNT, M.D., M.P.H., and ALLEN L. PELLETIER, M.D. University of Tennessee Health Science Center, Memphis, Tennessee Rosacea is a common,
More informationLMMG New Medicine Recommendation
LMMG New Medicine Recommendation Brimonidine (Mirvaso ) gel for facial erythema of rosacea in adults 18 years and over LMMG Recommendation: BLACK Brimonidine gel is not recommended for use to treat symptomatic
More informationThursday 21 st August Skin Problems
Thursday 21 st August 2014 Skin Problems Skin Problems The Sun and the Skin Sun Damage Recognising the early signs of skin cancer The Big 3 inflammatory condi=ons Acne & Rosacea Eczema (Including Seborrhoeic
More informationF r e q u e n t l y A s k e d Q u e s t i o n s
Acne who specializes in treating skin problems) about how you can help prevent acne and if treatment would help you. Q: What is acne? A: Acne is a disorder that causes outbreaks of skin lesions commonly
More informationSTUDY. A Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel in the Topical Treatment of Papulopustular Rosacea
A Comparison of 15% Azelaic Acid Gel and 0.75% Metronidazole Gel in the Topical of Papulopustular Rosacea Results of a Randomized Trial STUDY Boni E. Elewski, MD; Alan B. Fleischer, Jr, MD; David M. Pariser,
More informationAtopic Eczema with detail on how to apply wet wraps
Atopic Eczema with detail on how to apply wet wraps Dr Carol Hlela Consultant Dermatologist Head of Unit, Department of Dermatology, Paediatrics Red Cross Children s Hospital, UCT Red Cross War Memorial
More informationRosacea: Rosacea is an elusive skin condition. Sufferers of Little Understood Disease May Soon Have New Treatment Options
Rosacea: Sufferers of Little Understood Disease May Soon Have New Treatment Options by G. Scott Herron, M.D., Ph.D. Rosacea is an elusive skin condition that is not well understood. Until now, there has
More informationAcne vulgaris is a disease of the pilosebaceous unit (i.e., the sebaceous glands and adjacent hair follicle).
Dr. Ghassan Salah Acne is a common, chronic inflammatory disorder of the pilosebaceous unit in which a microcomedo develops as the initial condition. The most common form of acne is acne vulgaris. Other
More informationROSACEA IS A CHRONIC CUTAneous. Cutaneous and Ocular Signs of Childhood Rosacea STUDY
STUDY Cutaneous and Ocular Signs of Childhood Rosacea Mélanie Chamaillard, MD; Bruno Mortemousque, MD; Franck Boralevi, MD; Claudia Marques da Costa, MD; Farida Aitali, MD; Alain Taïeb, MD; Christine Léauté-Labrèze,
More informationAdvanced facials Week 1A T1 2016
Advanced facials Week 1A T1 2016 Sensitive skin Erythemic skin Sensitivity Characteristics Reacts to external stimuli by becoming red/blotchy More easily irritated Most often fair / red hair History of
More informationACNE UPDATE 2017 FACULTY DISCLOSURE ACNE UPDATE
ACNE UPDATE 2017 PATRICIA TREADWELL, M.D. PROFESSOR OF PEDIATRICS AND DERMATOLOGY IU SCHOOL OF MEDICINE FACULTY DISCLOSURE I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationRosacea Management. Review Article
Review Article Received: February 23, 2016 Accepted: April 14, 2016 Published online: May 18, 2016 Rosacea Management Manal Abokwidir Steven R. Feldman Department of Dermatology, Center for Dermatology
More informationبالدويدات الشعرية الاجربة التهاب= Demodex folliculitis. Rosacea
Rosacea ROSACEA Despite universal recognition, rosacea remains a controversial topic in dermatology, largely because of its uncertain pathophysiology and clinical variation. Practitioners and the public
More informationROSACEA. ETIOLOGICAL ASPECTS AND STAGING
Analele Universităţii din Oradea, Fascicula Protecţia Mediului Vol. XXVI 2016 ROSACEA. ETIOLOGICAL ASPECTS AND STAGING Bonta Marinela*, Bud Corina** *University of Oradea, Faculty of Medicine and Pharmacy,
More information06-May-15. Rosacea, Perioral Dermatitis, Optimizing Management,Tips and Traps
Rosacea, Perioral Dermatitis, Optimizing Management,Tips and Traps Rodney Sinclair Professor of Dermatology University of Melbourne & Epworth Healthcare 1 Predominantly erythematotelangiectatic rosacea
More informationRosacea is a chronic, inflammatory skin disease that affects primarily
The new england journal of medicine Caren G. Solomon, M.D., M.P.H., Editor Rosacea Esther J. van Zuuren, M.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationThough it represents one of the more commonly seen
The marriage of standard rosacea therapies and light-based interventions sets the bar for successful rosacea therapy. By David F. Horne, MD and Diane S. Berson, MD Though it represents one of the more
More informationInteresting Case Series. Rhinophyma
Interesting Case Series Rhinophyma Jake Laun, BS, Jared Gopman, BS, Joshua B. Elston, MD, and Michael A. Harrington, MD Department of Surgery, Division of Plastic Surgery, University of South Florida Morsani
More information..GAL D ERMA. Swiss Summary of the Risk Management Plan for Soolantra (ivermectin cream lomg/g) Galderma International
Page 1 of7 Swiss Summary of the Risk Management Plan for Soolantra (ivermectin cream lomg/g) Galderma International Version Number: 1.0 Document Date: 16-February-2017 Page 2 of7 Summary of the Risk Management
More informationTreatment of Refractory Rosacea with a Dual Wavelength Long- Pulsed 755-nm Alexandrite and 1,064-nm Nd:YAG Laser
Med Laser 2018;7(1):47-51 https://doi.org/10.25289/ml.2018.7.1.47 pissn 2287-8300 ㆍ eissn 2288-0224 Treatment of Refractory Rosacea with a Dual Wavelength Long- Pulsed 755-nm Alexandrite and 1,064-nm Nd:YAG
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Tacrolimus 0.1% Ointment Tacrolimus
PACKAGE LEAFLET: INFORMATION FOR THE USER Tacrolimus 0.1% Ointment Tacrolimus Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More informationPackage leaflet: Information for the patient. IsotrexIN Gel erythromycin 2% and isotretinoin 0.05%
Package leaflet: Information for the patient IsotrexIN Gel erythromycin 2% and isotretinoin 0.05% Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationTop 10 Skin Problems
THE UK GUIDE Top 10 Skin Problems Learn how a Dermatologist can solve your frustrating challenges with skin, scalp, hair and nails Jennifer Crawley MBChB, BSc (Hons), MRCP (Derm) BAD British Association
More informationReview patient presentations and pathophysiology. Discuss Treatment options Tried and true New and upcoming. Prevention and Counselling
Speaker: Janssen Consultant: Valeant, Allergan Drinker: Stone, Pizza Port, Lost Abbey Review patient presentations and pathophysiology Discuss Treatment options Tried and true New and upcoming Prevention
More informationPlease note that this information leaflet is for men, there is a separate information leaflet for women.
ISOTRETINOIN - MALE Please note that this information leaflet is for men, there is a separate information leaflet for women. What are the aims of this leaflet? This leaflet has been written to help you
More informationDOSAGE AND ADMINISTRATION Apply a thin layer of FINACEA Gel twice daily to affected area(s).
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FINACEA Gel safely and effectively. See full prescribing information for FINACEA Gel. FINACEA (azelaic
More informationNEHSNORTH EASTERN HEALTH SPECIALISTS
COSMETIC DERMATOLOGY NEHSNORTH EASTERN HEALTH SPECIALISTS nehs.com.au CONSENT FORM VASCULAR Treatment with BBL & LASERS I, DOB:, of authorize of North Eastern Health Specialist to perform hair removal
More informationX-Plain Acne Reference Summary
X-Plain Acne Reference Summary Nearly 17 million people in the United States have acne, making it one of the most common skin diseases in the USA. Although acne is not a serious health threat, severe acne
More informationCHANGING THE FACE OF ROSACEA MANAGEMENT
A SUPPLEMENT TO Skin & Allergy News CHANGING THE FACE OF ROSACEA MANAGEMENT Chair Henry H. Roenigk, Jr., MD Professor Emeritus Northwestern University Medical School Arizona Advanced Dermatology Scottsdale
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationClinical indicators of rosacea progression: a topographic evaluation according to subtype and severity
Hong Kong J. Dermatol. Venereol. (2017) 25, 161-169 Original Article Clinical indicators of rosacea progression: a topographic evaluation according to subtype and severity JS Hong, G Jo, HS Park, HS Yoon,
More informationA case of rosacea fulminans in a pregnant woman
Hong Kong J. Dermatol. Venereol. (2018) 26, 122-126 Views and Practice A case of rosacea fulminans in a pregnant woman JE Seol, SH Park, JU Kim, GJ Cho, SH Moon, H Kim Introduction Rosacea fulminans (RF)
More informationNasolacrimal Duct Blockage
The eyelids play a key role in protecting the eyes. They help spread moisture (tears) over the surface of the eyes when they close (for example, while blinking); thus, they help prevent the eyes from becoming
More informationACNE BOOT CAMP TOPICAL THERAPY BASICS
ACNE BOOT CAMP TOPICAL THERAPY BASICS Lawrence J Green, MD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington DC Relevant Disclosures Investigator -Allergan,
More informationPRODUCT MONOGRAPH TABLE OF CONTENTS. p. 8 p. 12
PRODUCT MONOGRAPH PRODUCT MONOGRAPH TABLE OF CONTENTS p. 8 p. 12 2 OVERVIEW OF ROSACEA Rosacea is a chronic skin disease with a relapsing-remitting course characterized by a variable spectrum of dermatologic
More information! Alcon! Carl Zeiss Meditec! Reichert! Thrombogenics! Zeavision! Kemin. ! CE Companies:
ROSACEA REVIEW Joseph J. Pizzimenti, OD, FAAO Associate Professor Nova Southeastern University pizzimen@nova.edu Financial Disclosure! Dr. Pizz has received honoraria from, participated in paid advisory
More informationLaser Resurfacing. Birmingham Regional Skin Laser Centre
What is laser resurfacing? Laser resurfacing is a treatment to help reduce the appearance of raised birthmarks, moles, acne scarring and sun-damaged skin. It can also help to reduce and reshape the nose
More informationTCIs are only available on prescription and are usually started by a dermatology specialist.
(TCIs) What are topical calcineurin inhibitors? Topical calcineurin inhibitors are treatments that alter the immune system and have been developed for controlling eczema. There are two types available:
More informationInvasive Pulsed-Type, Bipolar, Alternating Current Radiofrequency Treatment Using Microneedle Electrodes for Nasal Rosacea
Med Laser 2017;6(1):32-36 https://doi.org/10.25289/ml.2017.6.1.32 pissn 2287-8300 ㆍ eissn 2288-0224 Invasive Pulsed-Type, Bipolar, Alternating Current Radiofrequency Treatment Using Microneedle Electrodes
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FINACEA Gel safely and effectively. See full prescribing information for FINACEA Gel. FINACEA (azelaic
More informationSudden Appearance of Indurated Erythematous Plaques on a Man's Face
Touro College and University System Touro Scholar NYMC Student Publications Students 2016 Sudden Appearance of Indurated Erythematous Plaques on a Man's Face Adam Carter New York Medical College Karthikeyan
More informationPulsed-dye laser treatment
What is pulsed dye laser treatment? Pulsed dye laser treatment is a treatment used to remove or lighten the colour of vascular lesions such as Port Wine Stains, Facial Red Veins, some complicated Haemangiomas,
More informationFigure 7.1 Figure 7.2 Figure 7.3
CASE 7 Patient: A 63 year-old Thai female from Pathumthani Chief Complaint: Progressive facial eruption in 1 month Present Illness: The lesions involved only facial area without itching or pain. No associated
More informationREVIEW. Rosemarie H. Liu, BS; Molly K. Smith, MD; Sameh A. Basta, MD; Evan R. Farmer, MD
REVIEW Azelaic Acid in the Treatment of Papulopustular Rosacea A Systematic Review of Randomized Controlled Trials Rosemarie H. Liu, BS; Molly K. Smith, MD; Sameh A. Basta, MD; Evan R. Farmer, MD Objective:
More informationUnilateral rhinophyma: report of a case and review
Plast esthet Res 2017;4:49-53 DOI: 10.20517/2347-9264.2017.08 Case Report Plastic and esthetic Research www.parjournal.net Open ccess : report of a case and review Scott Walter 1, Steven Krueger 2, Jonathan
More informationRead all of this leaflet carefully before you start using this medicine because it contains important information for you.
Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end
More informationDoxycycline/Minocycline Step Therapy Criteria Program Summary
This criteria applies to Commercial, NetResults F series and Health Insurance Marketplace formularies. OBJECTIVE The intent of the Doxycycline/Minocycline Step Therapy (ST) program is to encourage the
More informationThe skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis
Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which
More informationWhat causes pimples in the first place? Dr. Melissa K. Levin, a board-certified dermatologist, breaks it down for us:
Ah, acne something that s plagued many of us during our teenage years, or may still be plaguing us currently as adults. Whether we re blessed to deal with a nose full of blackheads or more serious, painful,
More informationTreatments used Topical including cleansers and moisturizer Oral medications:
Discipline: Dermatology Extended Topic: Acne & Rosacea : Onset: Location: Face Chest Back Menses if female: Regular Irregular PCOS Treatments used Topical including cleansers and moisturizer Oral medications:
More informationRosacea Update: Rosacea pathogenesis. Rosacea genetics. Disclosures. Rosacea: Etiology? Th1/Th17 is activated in rosacea skin
Winter Clinical Big Island 20 min Rosacea Update: 2017 Diane M. Thiboutot, M.D. Professor of Dermatology The Pennsylvania State University College of Medicine Hershey, PA Disclosures Investigator or consultant
More informationPulsed Dye Laser Treatment Combined with Oral Minocycline Reduces Recurrence Rate of Rosacea
pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 29, No. 5, 2017 https://doi.org/10.5021/ad.2017.29.5.543 ORIGINAL ARTICLE Pulsed Dye Laser Treatment Combined with Oral Minocycline Reduces Recurrence
More informationRelevant Disclosures. Investigator/Consultant-Allergan. Investigator-Galderma
Rosacea Update 2018 Lawrence J Green, MD Associate Clinical Professor Department of Dermatology George Washington University School of Medicne Washington DC Relevant Disclosures Investigator/Consultant-Allergan
More informationInformation and Consent For Intracel
Information and Consent For Intracel What is Intracel? Intracel is a state of the art treatment for stimulating skin without the down time of total resurfacing using traditional invasive treatments. The
More informationCUTIS. Although recommendations on the management. Do Not Copy
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea James Q. Del Rosso, DO; Diane Thiboutot, MD; Richard Gallo,
More informationPrescribing Information
Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division
More informationPeriocular skin cancer
Periocular skin cancer Information for patients Skin cancer involving the skin of the eyelid or around the eye is called a periocular skin cancer. Eyelid skin cancers occur most often on the lower eyelid,
More informationContact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age
Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Dermatology Department The aim of this leaflet is to give you information about contact allergy
More informationCONTRAINDICATIONS None. (4)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FINACEA FOAM safely and effectively. See full prescribing information for FINACEA FOAM. FINACEA (azelaic
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abnormal wound healing Acne and cybereducation, 131 and Google, 129 131 and online dangers, 131, 132 reliable online resources on, 130 self-proclaimed
More informationAzelaic Acid 15% Gel: The Versatile Foundation of Combination Therapy in Mild to Moderate Rosacea in Various Patient Types COS DERM
Review Azelaic Acid 15% Gel: The Versatile Foundation of Combination Therapy in Mild to Moderate Rosacea in Various Patient Types Jeanine Downie, MD Rosacea is a common, chronic dermatologic condition
More informationRosacea in the Pediatric Population
CONTINUING MEDICAL EDUCATION Nicole L. Lacz, MD; Robert A. Schwartz, MD, MPH GOAL To gain a thorough understanding of rosacea in the pediatric population OBJECTIVES Upon completion of this activity, dermatologists
More informationINTRODUCTION. Printed in Great Britain. Correspondence Kevin Kavanagh Received 8 June 2013 Accepted 15 November 2013
Journal of Medical Microbiology (214), 63, 258 262 DOI 1.199/jmm..65136- Correlation between serum reactivity to Demodexassociated Bacillus oleronius proteins, and altered sebum levels and Demodex populations
More informationNEHSNORTH EASTERN HEALTH SPECIALISTS
COSMETIC DERMATOLOGY NEHSNORTH EASTERN HEALTH SPECIALISTS nehs.com.au CONSENT FORM TREATMENT OF PIGMENTATION BBL BroadBand Light I, DOB:, of authorize of North Eastern Health Specialist to perform acne
More informationCutaneous rosacea: a thorough overview
32 Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management James Q. Del Rosso Del Rosso Dermatology Research Center Las Vegas, Nevada The
More informationACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy
ACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy Robert S. Berger, MD, FAAD, FASDS., Assistant Professor, Department of Dermatology, The Johns Hopkins University, Baltimore, Private
More informationAlcohol should be avoided for 3 days prior to surgery and 2 days after the procedure.
Mohs Surgery Information Packet Be sure to bring the following to your appointment: Insurance Card Insurance Referral ( If required by your insurance) Name and address of your primary care provider as
More informationBBLs BroadBand Light. Daryl Mossburg, RN BSN Clinical Specialist Sciton, Inc. All rights reserved.
BBLs BroadBand Light Daryl Mossburg, RN BSN Clinical Specialist 1 2009 Sciton, Inc. All rights reserved. BBL - BroadBand Light BBL module incorporated into JOULE BBLs Standalone System 2 2009 Sciton, Inc.
More informationPROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP
PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP A HEALTHY 4-WEEK-OLD INFANT WITH ACNE A 4-week-old infant was brought to the pediatrician s office by his parents following the appearance
More informationINFLAMMATORY BOWEL DISEASE AND SKIN HEALTH KARA N. SHAH, MD, PHD KENWOOD DERMATOLOGY MARCH 4, 2018
INFLAMMATORY BOWEL DISEASE AND SKIN HEALTH KARA N. SHAH, MD, PHD KENWOOD DERMATOLOGY MARCH 4, 2018 DISCLOSURES I HAVE NO RELEVANT FINANCIAL DISCLOSURES INTRODUCTION Structure and function of the skin IBD
More informationScheffer C.G. Tseng, MD, PhD
Demodex: when mites are causing your eye irritation? Scheffer C.G. Tseng, MD, PhD Table of Contents Chapter 1: Introduction Chapter 2: Eye Mites? Gross! What are They? And What Do They Do? Chapter 3: Are
More informationNote for John Doe on 02/08/ Chart 17492
Note for John Doe on 02/08/2005 - Chart 17492 Chief Complaint (1/1): This 35-year-old male presents today for evaluation of acne. Acne HPI: Patient indicates acne is located on the dorsum of nose and manifest
More informationTSC and facial angiofibromas
TSC and facial angiofibromas Contents TSC and facial angiofibromas P3 What are facial angiofibromas (skin lesions/growths)? P4 Treatment Laser treatment Treatment using creams and ointments P8 Information
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationAllergic versus Contact
Allergic versus Contact Dermatitis Julie Sterbank, DO Assistant Clinical Professor Allergy/Immunology MetroHealth Medical Center/Case Western Reserve University Disclosure I have no financial disclosures
More informationreversing erythrotelangiectatic rosacea naturally the raw vegan plant based detoxification regeneration workbook for healing patients volume 2
DOWNLOAD OR READ : REVERSING ERYTHROTELANGIECTATIC ROSACEA NATURALLY THE RAW VEGAN PLANT BASED DETOXIFICATION REGENERATION WORKBOOK FOR HEALING PATIENTS VOLUME 2 PDF EBOOK EPUB MOBI Page 1 Page 2 healing
More informationDoxycycline/Minocycline Step Therapy Criteria Program Summary
Doxycycline/Minocycline Step Therapy Criteria Program Summary Step therapy applies to Commercial and Health Insurance Marketplace formularies only. OBJECTIVE The intent of the Doxycycline/Minocycline Step
More informationTreating your skin condition with Narrowband ultraviolet B radiation (NB-UVB)
Treating your skin condition with Narrowband ultraviolet B radiation (NB-UVB) Introduction You have been referred to the Phototherapy department at Colchester General Hospital for a course of narrowband
More informationDr A Anzarut, MSc, CIP, MD, FRCSC
Dr A Anzarut, MSc, CIP, MD, FRCSC Plastic and Cosmetic Surgery ASSH Fellowship trained hand surgeon 201 2763 Beverly Street, Duncan, British Columbia Tel: (250) 597 2064 Fax: (250) 597-1297 PATIENT INFORMATION
More informationICHTHYOSIS. What are the aims of this leaflet?
ICHTHYOSIS What are the aims of this leaflet? This leaflet has been written to help you understand more about ichthyosis. It will tell you what it is, the types of ichthyosis, what can be done about it,
More informationLaser Skin Rejuvenation
Laser Skin Rejuvenation Laser resurfacing, which is also known as laser peeling, is an effective facial rejuvenation technique that can produce long-lasting results. Over time, factors such as sun damage,
More informationWhat are the symptoms of a vulval skin condition?
Information for you Published in December 2013 Skin conditions of the vulva About this information This information is for you if you want to know about skin conditions affecting the vulva. If you are
More information